Latest acquisitions in the Medical Devices market

30/10/2020
Diego Gutiérrez
Latest acquisitions in the Medical Devices market

The market for medical devices is a mature market: the acquisitionsincreased significantly in 2014 and indicate that they will continue to grow in 2019 and beyond. 

Baker Tilly analyses which are the most important acquisitions in the market. But first, the sector is explained. Medical devices refers to any instrument, apparatus, appliance, implement, machine, implant... Medical devices are essential for the safe and effective prevention, diagnosis, treatment and rehabilitation of disease and illness. 

Johnson & Johnson and Auris Health  

Latest acquisitions in the Medical Devices market

Multinational Johnson & Johnson has reached an agreement to buy Auris Health for $3.4 billion with the aim of accelerating its entry into robotics, simplifying surgery, boosting efficiency, reducing complications and improving patient outcomes.

Auris Health is a technology developer specialising in lung cancer treatment, as part of its creation of a digitally connected ecosystem in the healthcare sector and also positions itself as a leader in surgical procedures. 

Johnson & Johnson is an American multinational manufacturer of medical devices, pharmaceuticals, personal care, fragrances and baby products founded in 1886. 

Siemens Healthineers and Corindus 

Siemens Healthineers and Corindus 

Siemens Healthineers has signed a merger agreement with the American company Corindus Vascular Robotics, a world leader in technology for robotic-assisted vascular interventions. Thanks to which it is positioned as one of the main leaders in the field of robotic vascular interventions and minimally invasive procedures. 

The acquisition is aimed at simplifying the current challenges faced by practitioners in their daily practice, as robotic-assisted minimally invasive procedures can reduce treatment times, increase treatment accuracy, raise levels of standardisation in clinical procedures and ultimately improve clinical outcomes, which represent the strategic focus of the Advanced Therapies business segment. 

En Baker Tilly Tech M&Asomos expertos en la sales of companies Shall we talk? 

Lastest news

State of technology M&A in Spain | Analysis August 2025

El mes de agosto, tradicionalmente más pausado en cuanto a transacciones corporativas, ha sorprendido en 2025 con una intensa actividad en el ámbito tecnológico en España. Se registraron operaciones de gran calado en segmentos como marketplaces digitales,...

Baker Tilly advises BSG on its acquisition of Copermática

The advisors for the sale and purchase of technology companies at Baker Tilly Tech M&A have advised Business Software Group (BSG) on its recent acquisition of Copermática, a company specialising in management software for professional firms and consultancies. With...

Do you want to sell or buy a company?

We are experts in M&A transactions in the technology sector.

Subscribe to our newsletter

    On which topic would you like to receive information?

    Request for information

    If you want to buy or sell a company, or need more information about our services, do not hesitate to contact us through the form.

    Or if you prefer, call us at:

    +34 946 42 41 42